Trial · NCT06207331
Effects of Atomized Dexmedetomidine on Lung Function in Patients With Chronic Obstructive Pulmonary Disease
NCT06207331, Not applicable, Terminated, The Second Affiliated Hospital of Chongqing Medical University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effects of Atomized Dexmedetomidine on Lung Function in Patients With Chronic Obstructive Pulmonary Disease. Trials, record NCT06207331. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06207331
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effects of Atomized Dexmedetomidine on Lung Function in Patients With Chronic Obstructive Pulmonary Disease
- NCT number
- NCT06207331
- Status
- Terminated
- Phases
- Not applicable
- Enrollment
- 6 participants, actual
- Lead sponsor
- The Second Affiliated Hospital of Chongqing Medical University
- Conditions
- Respiratory Function Tests, Chronic Obstructive Pulmonary Disease, Dexmedetomidine
- Interventions
- Dexmedetomidine 0.5 μg/kg, Dexmedetomidine 1 μg/kg, Saline
- First posted
- 2024-01-17
- Last updated
- 2025-05-31
Source ClinicalTrials.gov
Registered outcomes19
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | FVC | 10 minutes and 30 minutes after administration of nebulized drugs | Forced vital capacity |
| Secondary | FEV1 | 10 minutes and 30 minutes after administration of nebulized drugs | Forced expiratory volume in one second |
| Secondary | FEV1/FVC% | 10 minutes and 30 minutes after administration of nebulized drugs | Forced expiratory volume in one second/Forced vital capacity |
| Secondary | MMEF | 10 minutes and 30 minutes after administration of nebulized drugs | maximal mid-expiratory flow curve |
| Secondary | PEF | 10 minutes and 30 minutes after administration of nebulized drugs | Peak expiratory flow |
| Secondary | BEV | 10 minutes and 30 minutes after administration of nebulized drugs | Back-extrapolation volume |
| Secondary | FET | 10 minutes and 30 minutes after administration of nebulized drugs | Forced expiratory time |
| Secondary | VC | 10 minutes and 30 minutes after administration of nebulized drugs | Vital capacity |
| Secondary | FEV1/VC | 10 minutes and 30 minutes after administration of nebulized drugs | Forced expiratory volume in one second/vital capacity |
| Secondary | FEF25%，FEF50%，FEF75%， | 10 minutes and 30 minutes after administration of nebulized drugs | forced expiratory flow at 25%, 50%, and 75% of FVC exhaled |
1 to 10 of 19Source ClinicalTrials.gov
See all 19 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers11
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06207331
GET https://conductscience.org/api/trials/v1/NCT06207331/registered